ハイパルトロフィック心筋症は,主に左心室外流管の阻害による左心室外流管の疾患である
Martin S Maron1, Iacopo Olivotto, Andrey G Zenovich
1Hypertrophic Cardiomyopathy Center, Division of Cardiology, Tufts-New England Medical Center, Boston, MA 02111, USA. mmaron@tufts-nemc.org
Circulation
|November 8, 2006
まとめ
ハイパルトロフィック心筋症 (HCM) は,しばしば阻害性疾患であり,患者の70%が左心室 (LV) 流出阻害を示しています. 運動エコーカルディオグラフィは,HCM患者の障害を特定し,治療を導くために重要である.
科学分野:
- 心臓病学 心臓病学
- 心血管医学 心血管医学
- クリニカルエコーカルディオグラフィー
背景:
- ハイパルトロフィック心筋症 (HCM) は,休息グラデーションに基づく非阻害性として伝統的に見られています.
- 以前の評価では,左心室 (LV) 外流管阻害の有病率を過小評価していた.
研究 の 目的:
- 大規模なHCMコホートにおけるLV流出管阻害の有病率と臨床的重要性を将来的に決定する.
- 静止状態および生理学的ストレス (運動) 中の阻害を評価する.
主な方法:
- 320人のHCM患者の将来性分析.
- 静止状態,ヴァルサルバ操作,運動心声撮影で,LV出流グラディエントの測定.
主要な成果:
- 70%の患者 (225/320) は,休息状態および/または運動中に LV 流出阻害を示した.
- 運動は,106人の患者 (53%) で,以前は最小限の休息グラデーションを示した障害を明らかにしました.
- ヴァルサルヴァの演習は,運動による阻害を過小評価した.
結論:
- HCMは主に阻害性疾患であり,ほとんどの評価された患者で阻害性が顕著である.
- 運動エコーカルディオグラフィは,しばしば心不全の症状と関連している阻害を特定するために不可欠です.
- 運動中の亜動脈グラデーションの定期的な評価は,休息阻害のないHCM患者に対して推奨されます.
関連する概念動画
01:26Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
01:22Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...